It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Education and cardiovascular disease (CVD) are inversely associated but the mediating factors have not been totally elucidated. Our aim was to analyze the mediating role of modifiable risk factors. Cohort study using the REGICOR population cohorts. Participants without previous CVD were included (n = 9226). Marginal structural models were used to analyze the association between education and CVD incidence at 6 years of follow-up. Mediation by modifiable risk factors (diabetes, dyslipidemia, hypertension, smoking, body mass index, and physical activity) was assessed using the counterfactual framework. Participants with a university degree had a CVD incidence hazard ratio (HR) of 0.51 (95% confidence interval (CI) = 0.30, 0.85), compared to those with primary or lower education. Only hypertension, BMI, and diabetes mediated the association between education and CVD incidence, accounting for 26% of the association (13.9, 6.9, and 5.2%, respectively). Sensitivity analyses showed that hypertension was the strongest mediator (average causal mediation effect [95% CI] = increase of 2170 days free of CVD events [711, 4520]). The association between education and CVD incidence is partially mediated by hypertension, BMI, and diabetes. Interventions to decrease the prevalence of these risk factors could contribute to diminish the CVD inequalities associated with educational level.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 CIBER of Cardiovascular Diseases (CIBERCV), ISCIII, Madrid, Spain; REGICOR Study Group. Cardiovascular Epidemiology and Genetics Group. Epidemiology and Public Health Program. IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
2 REGICOR Study Group. Cardiovascular Epidemiology and Genetics Group. Epidemiology and Public Health Program. IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; School of Pharmacy, University of Barcelona, Barcelona, Spain
3 REGICOR Study Group. Cardiovascular Epidemiology and Genetics Group. Epidemiology and Public Health Program. IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; ABS Florida Sud and Cardiovascular Research Group in Primary Care (MACAP Costa Ponent), Primary Care Research Institute Jordi Gol, Catalan Institute of Health, l’Hospitalet de Llobregat, Barcelona, Spain
4 Vascular Health Research Group (ISV-Girona). Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain; Translab Research Group, Department of Medical Sciences, School of Medicine, University of Girona, Girona, Spain; Institut Català de la Salut, Àmbit d’atenció Primaria, Girona, Spain
5 Translab Research Group, Department of Medical Sciences, School of Medicine, University of Girona, Girona, Spain; Lipid and Atherosclerosis Unit and Department of Internal Medicine, Hospital de Blanes, Girona, Spain
6 Vascular Health Research Group (ISV-Girona). Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain; Institut d’Investigació Biomèdica de Girona (IDIBGI), Hospital Universitari Dr. Josep Trueta, Girona, Spain